CTOs on the Move

Claims Processing and Receivables

www.cpr911.com

 
Claims Processing and Receivables Inc. is a Milwaukee, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.cpr911.com
  • 5225 N Ironwood Rd
    Milwaukee, WI USA 53217
  • Phone: 414.963.1183

Executives

Name Title Contact Details

Similar Companies

Careage Hills

Careage Hills is a Cherokee, IA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Co-Dx

Real-time PCR testing for everyone Watch the video Amplifying human potential through real-time PCR It all starts with a single sample. Add chemistry, heat, and light to make the fragments of a single virus visible by amplification up to a billion fold...

Cypress Creek EMS

Cypress Creek EMS is a Houston, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Comprehensive NeuroScience

Comprehensive NeuroScience, Inc. is a Hollywood, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Allergen Research

Aimmune is a clinical-stage biopharmaceutical company advancing a new therapeutic approach, including the development of proprietary product candidates, for the treatment of peanut and other food allergies. Our mission is to improve the lives of people with food allergies by developing and commercializing proprietary desensitization therapies that safely and reliably protect them from accidental exposure to food allergens. We aim to address food allergies by providing a treatment option that goes beyond the current protocols of avoiding exposure to food allergens and carrying epinephrine for administration in case of accidental exposure. Our CODIT™ system is based on extensive independent scientific research demonstrating that most patients with food allergies can become desensitized to the allergens, or proteins, in a particular food through the oral administration of gradually increasing amounts of the allergens. In oral immunotherapy (OIT), a very small amount of an allergen is administered on a daily basis and then regularly increased until desensitization to a certain amount of the allergen has been achieved. We plan to develop and commercialize standardized, pharmaceutical-grade food allergens for our CODIT™ (characterized oral desensitization immunotherapy) system, our system for OIT. Our lead product candidate, AR101, is a standardized, complex mixture of 13 naturally occurring proteins and pharmaceutical-grade ingredients that, with the CODIT system of gradual, controlled updosing and ongoing maintenance dosing, has obtained meaningful desensitization to peanut allergens in our initial clinical studies.